CLASIFICACIONES – Carrera del Barro – La Barca Extreme
PRODUCCIÓN CIENTÍFICA
Artículos publicados en revistas científicas
A continuación recopilamos y enlazamos algunos artículos publicados con las investigaciones desarrolladas por el grupo de investigación (CTS-963) de la Cátedra “Doctores Galera y Requena de Investigación en Células Madre Cancerígenas”.
Más info: catedracmc@ugr.es
- What’s new in treatment of pancreatic cancer: a patent review (2010–2017) – Journal Expert Opinion on Therapeutic Patents – 12/07/2017 – (http://www.tandfonline.com/doi/full/10.1080/13543776.2017.1349106?scroll=top&needAccess=true)
Validation of suitable normalizers for miR expression patterns analysis covering tumour heterogeneity – SCIENTIFIC REPORTS – 4/01/2017 – (http://www.nature.com/articles/srep39782)
- Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells – SCIENTIFIC REPORTS (http://www.nature.com/articles/srep18772)
- Interactions between Adipocytes and Breast Cancer Cells Stimulate Cytokine Production and Drive Src/Sox2/miR-302b–Mediated Malignant Progression – CANCER RESEARCH JOURNALS (http://cancerres.aacrjournals.org/content/76/2/491)
- Balancing the effect of corona on therapeutic efficacy and macrophage uptake of lipid nanocapsules – ELSEVIER (http://www.sciencedirect.com/science/article/pii/S0142961215004366)
- EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer – IMPACT JOURNALS – ONCOTARJET (http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5b%5d=2217)
- HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib – IMPACT JOURNALS – ONCOTARJET (http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=1962)
- The impact of PKR activation: from neurodegeneration to cancer – THE FASEB JOURBNALS (http://www.fasebj.org/content/28/5/1965.full.pdf)
- Bozepinib, a novel small antitumor agent, induces PKR-mediated apoptosis and synergizes with IFNα triggering apoptosis, autophagy and senescence – DOVEPRESS – (https://www.dovepress.com/bozepinib-a-novel-small-antitumor-agent-induces-pkr-mediated-apoptosis-peer-reviewed-article-DDDT)
- Cadmium Modifies the Cell Cycle and Apoptotic Profiles of Human Breast Cancer Cells Treated with 5-Fluorouracil – INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES – (http://www.mdpi.com/1422-0067/14/8/16600)
- In vitro treatment of carcinoma cell lines with pancreatic (pro)enzymes suppresses the EMT programme and promotes cell differentiation – CELLULAR ONCOLOGY JOURNAL – INTERNATIONAL SOCIETY FOR CELLULAR ONCOLOGY (http://link.springer.com/article/10.1007/s13402-013-0134-8)
- Synthesis and Characterization of Lipid Immuno-Nanocapsules for Directed Drug Delivery: Selective Antitumor Activity against HER2 Positive Breast-Cancer Cells – BIO MACROMOLECULES – (http://pubs.acs.org/doi/abs/10.1021/bm401103t)
- The Chemotherapeutic Drug 5-Fluorouracil Promotes PKR-Mediated Apoptosis in a p53- Independent Manner in Colon and Breast Cancer Cells – PLOS ONE JOURNALS – (http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0023887)
- Cadmium influences the 5-fluorouracil cytotoxic effects on breast cancer cells – EUROPEAN JOURNAL OF HISTOCHEMISTRY – (http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0023887)
- Anti-proliferative activity of 2,6-dichloro-9- or 7-(ethoxycarbonylmethyl)-9H– or 7H-purines against several human solid tumour cell lines – ELSEVIER – http://www.sciencedirect.com/science/article/pii/S0223523414001329
- 5-Fluorouracil derivatives: a patent review (2012 – 2014) – EXPERT OPINION ON THERAPEUTIC PATENTS – (http://www.tandfonline.com/doi/full/10.1517/13543776.2015.1056736)
- Enantiospecific Synthesis of Heterocycles Linked to Purines: Different Apoptosis Modulation of Enantiomers in Breast Cancer Cells – CURRENT MEDICINAL CHEMISTRY – (http://www.eurekaselect.com/115347/article)
- Cancer suicide gene therapy: a patent review – EXPERT OPINION ON THERAPEUTIC PATENTS – (http://www.tandfonline.com/doi/full/10.1080/13543776.2016.1211640)
También te puede interesar:
